RevBio Revenue and Competitors

Location

#384

Growjo Ranking

Medical

Industry

Estimated Revenue & Valuation

  • RevBio's total funding is $18M.

Employee Data

  • RevBio has 30 Employees.(i)
  • RevBio grew their employee count by 7% last year.

RevBio's People

NameTitleEmail/Phone
1
CEO, FounderReveal Email/Phone
2
CMOReveal Email/Phone
3
Co-founderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M170%N/AN/A
#2
N/A40%N/AN/A
#3
$7.5M1147%N/AN/A
#4
$7.5M7233%N/AN/A
#5
N/A1755%N/AN/A
#6
$7.5M48-2%N/AN/A
#7
N/A3233%N/AN/A
#8
N/A11537%N/AN/A
#9
$1.7M9-18%N/AN/A
#10
N/A70-17%N/AN/A
Add Company

What Is RevBio?

RevBio was started with one goal in mind—to end medicine’s 50 year search for a biocompatible bone adhesive. Effective for bone-to-bone as well as bone-to-metal wet field applications, Tetranite® is a revolutionary biomaterial that promises to transform bone repair—for both patients and clinicians. Inspired by the marine animal the sandcastle worm, Tetranite is simple chemistry. Bioengineered from the worm’s secreted protein, our synthetic adhesive is the only patented biomaterial which satisfies both the required and desired properties for a bone adhesive: wet field performance, multi-surface bonding, rapid mechanical stability, and controlled biodegradability. The properties of Tetranite™ include the ability to provide immediate fixation of bone to bone and bone to metal. This adhesive has been shown in multiple animal studies to be a non-toxic and effective way of repairing bone fractures and defects as well as securing implant devices. Existing data has also shown that Tetranite™ is reabsorbed and replaced with new bone during the natural process of bone remodeling by acting as a scaffold to facilitate bone growth over time.

keywords:N/A

$18M

Total Funding

30

Number of Employees

N/A

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5M303%N/A
#2
$6.5M3011%N/A
#3
$6.7M3115%N/A
#4
$4.3M31-14%N/A
#5
$3.5M317%N/A